Ligand validation:5L8R

CHL: CHLOROPHYLL B

CHL is a Ligand Of Interest in 5L8R designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5L8R_CHL_2_515	66%	39%	0.093	0.952	1	1.38	2	10	3	3	70%	0.697
5L8R_CHL_2_526	61%	45%	0.139	0.927	0.86	1.24	3	11	7	4	100%	1
5L8R_CHL_2_513	60%	38%	0.113	0.946	1.05	1.35	4	8	5	3	73%	0.7273
5L8R_CHL_1_521	60%	42%	0.127	0.938	0.96	1.28	4	8	6	4	85%	0.8485
5L8R_CHL_4_314	58%	26%	0.127	0.947	1.09	1.9	4	14	4	3	77%	0.7727
5L8R_CHL_1_514	56%	42%	0.131	0.916	0.86	1.36	2	11	8	4	92%	0.9242
5L8R_CHL_1_512	52%	35%	0.108	0.916	0.98	1.57	3	12	6	3	71%	0.7121
5L8R_CHL_3_314	50%	32%	0.107	0.908	1.03	1.67	4	12	7	3	71%	0.7121
5L8R_CHL_2_516	48%	42%	0.122	0.89	0.91	1.34	3	10	2	4	85%	0.8485
5L8R_CHL_4_316	47%	38%	0.145	0.897	0.98	1.42	4	11	8	4	92%	0.9242
5L8R_CHL_2_512	37%	26%	0.108	0.856	1.14	1.83	3	13	6	3	71%	0.7121
5L8R_CHL_4_313	35%	36%	0.124	0.863	1.02	1.48	4	11	1	3	71%	0.7121
5L8R_CHL_4_317	25%	30%	0.123	0.817	1.07	1.72	4	12	4	3	65%	0.6515
7DKZ_CHL_4_307	74%	7%	0.109	0.98	2.17	2.56	15	20	5	3	77%	0.7727
4Y28_CHL_4_4011	59%	19%	0.13	0.953	1.89	1.56	10	11	13	3	77%	0.7727
2X20_CHL_M_601	89%	16%	0.098	0.977	1.72	1.97	11	21	1	3	100%	0.9773
1RWT_CHL_C_609	87%	21%	0.102	0.973	1.52	1.81	11	10	2	5	100%	1
6S2Y_CHL_A_1001	71%	8%	0.139	0.961	1.97	2.57	18	23	4	3	100%	1
4LCZ_CHL_A_312	67%	11%	0.14	0.949	2.27	1.92	14	16	3	4	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.